Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 234 (TMEM234) is a protein encoded by the TMEM234 gene, predicted to be an integral component of the membrane. It belongs to a putative transmembrane protein family, with limited functional information available in humans. Mouse studies suggest a possible role in glomerular filtration and kidney development processes. The gene is associated with hereditary retinal dystrophy but is not currently characterized as a therapeutic target and has no known interacting drugs or direct disease mechanisms identified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 234 (TMEM234).